Nomura Holdings Inc. Raises Holdings in Amedisys, Inc. (NASDAQ:AMED)

Nomura Holdings Inc. boosted its stake in shares of Amedisys, Inc. (NASDAQ:AMEDFree Report) by 604.2% in the 4th quarter, HoldingsChannel reports. The fund owned 49,297 shares of the health services provider’s stock after buying an additional 42,297 shares during the quarter. Nomura Holdings Inc.’s holdings in Amedisys were worth $4,686,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of AMED. Pentwater Capital Management LP boosted its holdings in Amedisys by 239.5% during the 3rd quarter. Pentwater Capital Management LP now owns 1,144,000 shares of the health services provider’s stock valued at $106,850,000 after acquiring an additional 807,000 shares during the period. Water Island Capital LLC raised its position in Amedisys by 185.0% during the 4th quarter. Water Island Capital LLC now owns 710,697 shares of the health services provider’s stock valued at $67,559,000 after purchasing an additional 461,368 shares during the last quarter. Norges Bank bought a new position in Amedisys during the 4th quarter valued at approximately $34,032,000. Segantii Capital Management Ltd bought a new position in Amedisys during the 4th quarter valued at approximately $32,776,000. Finally, Bank of Nova Scotia bought a new position in Amedisys during the 3rd quarter valued at approximately $26,671,000. 94.36% of the stock is currently owned by hedge funds and other institutional investors.

Amedisys Stock Up 0.0 %

AMED stock traded up $0.04 on Tuesday, reaching $91.82. 1,979 shares of the company traded hands, compared to its average volume of 283,972. Amedisys, Inc. has a one year low of $89.55 and a one year high of $97.36. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.31. The firm has a fifty day simple moving average of $93.02 and a 200-day simple moving average of $93.55.

Amedisys (NASDAQ:AMEDGet Free Report) last posted its quarterly earnings data on Wednesday, April 24th. The health services provider reported $1.03 earnings per share for the quarter, beating analysts’ consensus estimates of $1.02 by $0.01. Amedisys had a positive return on equity of 12.85% and a negative net margin of 0.91%. The company had revenue of $571.41 million during the quarter, compared to analyst estimates of $565.38 million. During the same quarter last year, the company earned $1.00 EPS. The firm’s revenue for the quarter was up 2.7% on a year-over-year basis. Sell-side analysts anticipate that Amedisys, Inc. will post 4.57 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research firms have commented on AMED. raised Amedisys from a “hold” rating to a “buy” rating in a research report on Saturday, May 4th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $101.00 price target on shares of Amedisys in a research report on Thursday, April 25th. Raymond James reaffirmed a “market perform” rating on shares of Amedisys in a research report on Tuesday, March 26th. Finally, Royal Bank of Canada increased their target price on Amedisys from $97.00 to $100.00 and gave the stock an “outperform” rating in a research report on Monday, March 25th. Five equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, Amedisys has an average rating of “Hold” and a consensus target price of $100.80.

Get Our Latest Report on Amedisys

About Amedisys

(Free Report)

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.

Featured Articles

Want to see what other hedge funds are holding AMED? Visit to get the latest 13F filings and insider trades for Amedisys, Inc. (NASDAQ:AMEDFree Report).

Institutional Ownership by Quarter for Amedisys (NASDAQ:AMED)

Receive News & Ratings for Amedisys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys and related companies with's FREE daily email newsletter.